Healthcare provider profile · identity verified

Rick Talley Waldo, M.D.

Internal Medicine · PLANO, TX · NPI 1992811335

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	515	142
Levothyroxine Sodium	Levothyroxine Sodium	313	87
Rosuvastatin Calcium	Rosuvastatin Calcium	285	80
Alprazolam	Alprazolam	188	45
Simvastatin	Simvastatin	181	52
Metoprolol Succinate	Metoprolol Succinate	180	52
Pantoprazole Sodium	Pantoprazole Sodium	179	50
Olmesartan Medoxomil	Olmesartan Medoxomil	177	48
Zolpidem Tartrate	Zolpidem Tartrate	156	40
Gabapentin	Gabapentin	153	49
Synthroid	Levothyroxine Sodium	149	34
Escitalopram Oxalate	Escitalopram Oxalate	148	39
Metformin Hcl Er	Metformin Hcl	143	44
Prednisone	Prednisone	141	99
Irbesartan	Irbesartan	134	38
Meloxicam	Meloxicam	131	46
Clonazepam	Clonazepam	129	32
Allopurinol	Allopurinol	122	30
Carvedilol	Carvedilol	118	33
Lisinopril	Lisinopril	118	37
Sertraline Hcl	Sertraline Hcl	111	35
Montelukast Sodium	Montelukast Sodium	105	34
Amlodipine Besylate	Amlodipine Besylate	102	34
Celecoxib	Celecoxib	101	32
Jardiance	Empagliflozin	99	30
Ipratropium Bromide	Ipratropium Bromide	95	40
Tamsulosin Hcl	Tamsulosin Hcl	94	32
Ozempic	Semaglutide	91	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	81	21
Pravastatin Sodium	Pravastatin Sodium	80	23
Trazodone Hcl	Trazodone Hcl	73	23
Benazepril Hcl	Benazepril Hcl	70	24
Indapamide	Indapamide	70	20
Methylprednisolone	Methylprednisolone	63	49
Famotidine	Famotidine	62	20
Tramadol Hcl	Tramadol Hcl	62	19
Citalopram Hbr	Citalopram Hydrobromide	60	16
Omeprazole	Omeprazole	59	16
Glimepiride	Glimepiride	58	15
Losartan Potassium	Losartan Potassium	57	16
Estradiol	Estradiol	56	19
Hydrochlorothiazide	Hydrochlorothiazide	55	17
Clonidine Hcl	Clonidine Hcl	51	15
Eliquis	Apixaban	51	13
Primidone	Primidone	48	14
Doxycycline Monohydrate	Doxycycline Monohydrate	44	39
Estradiol (Once Weekly)	Estradiol	44	13
Atenolol	Atenolol	42	12
Bupropion Xl	Bupropion Hcl	40	11
Telmisartan	Telmisartan	40	11
Topiramate	Topiramate	39	11
Warfarin Sodium	Warfarin Sodium	38	suppressed
Propranolol Hcl Er	Propranolol Hcl	37	11
Albuterol Sulfate Hfa	Albuterol Sulfate	36	12
Azithromycin	Azithromycin	36	34
Pioglitazone Hcl	Pioglitazone Hcl	36	suppressed
Symbicort	Budesonide/Formoterol Fumarate	35	suppressed
Testosterone Cypionate	Testosterone Cypionate	35	15
Diazepam	Diazepam	34	suppressed
Isradipine	Isradipine	32	suppressed
Spironolactone	Spironolactone	32	11
Bumetanide	Bumetanide	31	11
Mirtazapine	Mirtazapine	31	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Metformin Hcl	Metformin Hcl	30	suppressed
Xarelto	Rivaroxaban	29	suppressed
Eplerenone	Eplerenone	27	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	11
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Furosemide	Furosemide	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	12
Nifedipine Er	Nifedipine	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Valsartan	Valsartan	21	suppressed
Colesevelam Hcl	Colesevelam Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Econazole Nitrate	Econazole Nitrate	19	12
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Levofloxacin	Levofloxacin	18	15
Mometasone Furoate	Mometasone Furoate	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Raloxifene Hcl	Raloxifene Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	17
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Icosapent Ethyl	Icosapent Ethyl	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Guanfacine Hcl	Guanfacine Hcl	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Finasteride	Finasteride	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Pioglitazone-Metformin	Pioglitazone Hcl/Metformin Hcl	14	suppressed
Potassium Chloride	Potassium Chloride	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Ramipril	Ramipril	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Nurtec Odt	Rimegepant Sulfate	12	suppressed
Estradiol (Twice Weekly)	Estradiol	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error